One of the significant implications of the MDR1 gene in toxicology is its role in multidrug resistance. Overexpression of P-glycoprotein can lead to decreased intracellular concentrations of chemotherapeutic agents, rendering them less effective. This mechanism is a significant challenge in the treatment of cancers, as tumors can exploit the MDR1 gene to resist chemotherapy.
